Matches in Wikidata for { <http://www.wikidata.org/entity/Q61980969> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q61980969 description "clinical trial" @default.
- Q61980969 description "ensayo clínico" @default.
- Q61980969 description "ensayu clínicu" @default.
- Q61980969 description "klinisch onderzoek" @default.
- Q61980969 description "клінічне випробування" @default.
- Q61980969 description "կլինիկական փորձարկում" @default.
- Q61980969 description "临床试验" @default.
- Q61980969 name "GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)" @default.
- Q61980969 type Item @default.
- Q61980969 label "GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)" @default.
- Q61980969 prefLabel "GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)" @default.
- Q61980969 P1050 Q61980969-6A98FCB5-9CED-41AF-9D0D-0999FF19CBBD @default.
- Q61980969 P1132 Q61980969-06755C0C-11DB-4F65-941D-8E6C59D732C1 @default.
- Q61980969 P1476 Q61980969-4EC0E15F-ACCA-43D4-B3E9-A7919688E9BA @default.
- Q61980969 P17 Q61980969-00A420DF-DE10-4468-8218-1B0A0F54AE49 @default.
- Q61980969 P17 Q61980969-3E0A3980-2D06-4563-8266-588BB1CB6D43 @default.
- Q61980969 P17 Q61980969-448AC16E-BDC2-4865-B1D0-6A002E1FFEE9 @default.
- Q61980969 P1813 Q61980969-4BE97DD1-C4E1-4965-9C59-863794320F77 @default.
- Q61980969 P2899 Q61980969-528FC155-90C6-4A57-84B7-049FB9F4E012 @default.
- Q61980969 P3098 Q61980969-9B67DB3A-96A1-49AB-9D1C-D23687A5FBD8 @default.
- Q61980969 P31 Q61980969-FBC07E39-CCD2-40BC-9731-5AA58A0E5D67 @default.
- Q61980969 P4844 Q61980969-FD352DAD-8E66-432F-A4A8-4E13018922E0 @default.
- Q61980969 P580 Q61980969-6A10B6C3-FD83-49C3-9E1F-361BC271CAA5 @default.
- Q61980969 P582 Q61980969-48B7B70A-C422-4357-A617-B36548CB04AC @default.
- Q61980969 P6099 Q61980969-D6945FF4-AD41-407E-86D9-28DBB0405500 @default.
- Q61980969 P6153 Q61980969-C00E9F17-7CB6-4904-8A4E-6EC313C004E8 @default.
- Q61980969 P8005 Q61980969-8CB6C23D-6E92-4998-AFEE-6565301A2BE3 @default.
- Q61980969 P8363 Q61980969-FEAD6A60-EE88-4464-B55A-1AA9727ABBD8 @default.
- Q61980969 P859 Q61980969-CF103561-510C-483C-94F5-AD8994BC20AF @default.
- Q61980969 P1050 Q12206 @default.
- Q61980969 P1132 "+311" @default.
- Q61980969 P1476 "A Randomized, Double-Blind, Placebo-Controlled, 2-arm Parallel-group, Multicenter Study With a 24-Week Treatment Period Assessing the Efficacy and Safety of AVE0010 in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin With or Without Sulfonylurea" @default.
- Q61980969 P17 Q17 @default.
- Q61980969 P17 Q865 @default.
- Q61980969 P17 Q928 @default.
- Q61980969 P1813 "GETGOAL-L-ASIA" @default.
- Q61980969 P2899 "+19" @default.
- Q61980969 P3098 "NCT00866658" @default.
- Q61980969 P31 Q30612 @default.
- Q61980969 P4844 Q6659956 @default.
- Q61980969 P580 "2009-03-01T00:00:00Z" @default.
- Q61980969 P582 "2010-06-01T00:00:00Z" @default.
- Q61980969 P6099 Q42824827 @default.
- Q61980969 P6153 Q158205 @default.
- Q61980969 P8005 Q76651189 @default.
- Q61980969 P8363 Q78089383 @default.
- Q61980969 P859 Q158205 @default.